In a multicenter, double-blind, randomized, placebo-controlled clinical study of the Ang II vaccine AngQb-Cyt006, 72 subjects with mild to moderate HTN underwent vaccination or were administered a placebo. The gene discussed is AGT; the disease is hypertensive disorder.